TCL Archive In Brief: HHS Drags Feet, NCI Considering Contract To Review Cancer Research Facility Needs October 14, 1983
TCL Archive Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA May 9, 1997
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive Yarbro Proposal, Clinical Research Should Be “Fun”, Done Without Grants/ Contracts, To Be Heard By ACCC September 10, 1982
